3-in-1 hypertension pill offers better success: Study
Wednesday - August 15, 2018 10:46 am ,
Category : HEALTH
Canberra Aug 15 (IANS) With over a billion people struggling to control their high blood pressure globally an Australian study suggests a "three-in-one" pill for better results.
The trial involved three drugs each at half dose in a single pill for early treatment. It met with success in 70 per cent of the cases in a targeted group the George Institute for Global Health (GIGH) said on Wednesday.
In conventional medication patients are treated with one drug at a very low dose which is increased over time with additional drugs added and increased in dosage to try to reach targets.
However the Australian-led trials showed that low-dose of the "three-in-one" pill helped almost three-fourth patients to lower their blood pressure compared to just around half receiving normal care Xinhua news agency reported.
"Our results could help millions reduce their risk of heart attack or stroke " said Ruth Webster of GIGH said. The study was published in JAMA a journal of the American Medical Association.
The findings could impact guidelines on treating hypertension globally said the institute.
--IANS in/sed
The trial involved three drugs each at half dose in a single pill for early treatment. It met with success in 70 per cent of the cases in a targeted group the George Institute for Global Health (GIGH) said on Wednesday.
In conventional medication patients are treated with one drug at a very low dose which is increased over time with additional drugs added and increased in dosage to try to reach targets.
However the Australian-led trials showed that low-dose of the "three-in-one" pill helped almost three-fourth patients to lower their blood pressure compared to just around half receiving normal care Xinhua news agency reported.
"Our results could help millions reduce their risk of heart attack or stroke " said Ruth Webster of GIGH said. The study was published in JAMA a journal of the American Medical Association.
The findings could impact guidelines on treating hypertension globally said the institute.
--IANS in/sed
